New oral drug for inflammatory bowel disease enters first human tests
Disease control
Recruiting now
This early-stage trial tests BDHK-2009, an experimental tablet for inflammatory bowel diseases like ulcerative colitis and Crohn's disease. The study involves 68 healthy adults aged 18 to 55 to see if the drug is safe and how the body handles it. Participants receive either a sin…
Phase: PHASE1 • Sponsor: Benethera (Shaoxing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC